208 related articles for article (PubMed ID: 10652479)
1. Recent advances with recombinant bacterial vaccine vectors.
Shata MT; Stevceva L; Agwale S; Lewis GK; Hone DM
Mol Med Today; 2000 Feb; 6(2):66-71. PubMed ID: 10652479
[TBL] [Abstract][Full Text] [Related]
2. Advances in the development of bacterial vector technology.
Kochi SK; Killeen KP; Ryan US
Expert Rev Vaccines; 2003 Feb; 2(1):31-43. PubMed ID: 12901595
[TBL] [Abstract][Full Text] [Related]
3. An overview of vaccine vectors.
Dorner F
Dev Biol Stand; 1995; 84():23-32. PubMed ID: 7796959
[No Abstract] [Full Text] [Related]
4. Attenuated salmonella and Shigella as carriers for DNA vaccines.
Xu F; Ulmer JB
J Drug Target; 2003; 11(8-10):481-8. PubMed ID: 15203916
[TBL] [Abstract][Full Text] [Related]
5. Listeria as a vaccine vector.
Bruhn KW; Craft N; Miller JF
Microbes Infect; 2007 Aug; 9(10):1226-35. PubMed ID: 17719258
[TBL] [Abstract][Full Text] [Related]
6. Salmonellae as oral vaccine carriers.
Schödel F; Curtiss R
Dev Biol Stand; 1995; 84():245-53. PubMed ID: 7796961
[No Abstract] [Full Text] [Related]
7. Bacterial systems for the delivery of eukaryotic antigen expression vectors.
Dietrich G; Spreng S; Gentschev I; Goebel W
Antisense Nucleic Acid Drug Dev; 2000 Oct; 10(5):391-9. PubMed ID: 11079578
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in the development of live, attenuated bacterial vectors.
Roland KL; Tinge SA; Killeen KP; Kochi SK
Curr Opin Mol Ther; 2005 Feb; 7(1):62-72. PubMed ID: 15732531
[TBL] [Abstract][Full Text] [Related]
9. Novel vaccination strategies based on recombinant Mycobacterium bovis BCG.
Dietrich G; Viret JF; Hess J
Int J Med Microbiol; 2003 Feb; 292(7-8):441-51. PubMed ID: 12635927
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Salmonella live vaccines with chromosomal expression cassettes for translocated fusion proteins.
Husseiny MI; Hensel M
Vaccine; 2009 Jun; 27(28):3780-7. PubMed ID: 19464562
[TBL] [Abstract][Full Text] [Related]
11. Applications of bacillus Calmette-Guerin and recombinant bacillus Calmette-Guerin in vaccine development and tumor immunotherapy.
Zheng YQ; Naguib YW; Dong Y; Shi YC; Bou S; Cui Z
Expert Rev Vaccines; 2015; 14(9):1255-75. PubMed ID: 26268434
[TBL] [Abstract][Full Text] [Related]
12. Recombinant Mycobacterium bovis BCG.
Bastos RG; Borsuk S; Seixas FK; Dellagostin OA
Vaccine; 2009 Nov; 27(47):6495-503. PubMed ID: 19720367
[TBL] [Abstract][Full Text] [Related]
13. Recombinant Salmonella vectors in vaccine development.
Curtiss R; Kelly SM; Tinge SA; Tacket CO; Levine MM; Srinivasan J; Koopman M
Dev Biol Stand; 1994; 82():23-33. PubMed ID: 7958478
[TBL] [Abstract][Full Text] [Related]
14. Selected prfA* mutations in recombinant attenuated Listeria monocytogenes strains augment expression of foreign immunogens and enhance vaccine-elicited humoral and cellular immune responses.
Yan L; Qiu J; Chen J; Ryan-Payseur B; Huang D; Wang Y; Rong L; Melton-Witt JA; Freitag NE; Chen ZW
Infect Immun; 2008 Aug; 76(8):3439-50. PubMed ID: 18474644
[TBL] [Abstract][Full Text] [Related]
15. Elicitation of predictable immune responses by using live bacterial vectors.
Drabner B; Guzmán CA
Biomol Eng; 2001 Mar; 17(3):75-82. PubMed ID: 11222981
[TBL] [Abstract][Full Text] [Related]
16. Live attenuated bacteria as vectors to deliver plasmid DNA vaccines.
Dietrich G; Spreng S; Favre D; Viret JF; Guzman CA
Curr Opin Mol Ther; 2003 Feb; 5(1):10-9. PubMed ID: 12669465
[TBL] [Abstract][Full Text] [Related]
17. Recombinant BCG Expressing Mycobacterium ulcerans Ag85A Imparts Enhanced Protection against Experimental Buruli ulcer.
Hart BE; Hale LP; Lee S
PLoS Negl Trop Dis; 2015 Sep; 9(9):e0004046. PubMed ID: 26393347
[TBL] [Abstract][Full Text] [Related]
18. New use of BCG for recombinant vaccines.
Stover CK; de la Cruz VF; Fuerst TR; Burlein JE; Benson LA; Bennett LT; Bansal GP; Young JF; Lee MH; Hatfull GF
Nature; 1991 Jun; 351(6326):456-60. PubMed ID: 1904554
[TBL] [Abstract][Full Text] [Related]
19. Can a 'flawless' live vector vaccine strain be engineered?
Galen JE; Levine MM
Trends Microbiol; 2001 Aug; 9(8):372-6. PubMed ID: 11514219
[TBL] [Abstract][Full Text] [Related]
20. Live bacterial delivery systems for development of mucosal vaccines.
Thole JE; van Dalen PJ; Havenith CE; Pouwels PH; Seegers JF; Tielen FD; van der Zee MD; Zegers ND; Shaw M
Curr Opin Mol Ther; 2000 Feb; 2(1):94-9. PubMed ID: 11249657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
